IVIG Supplementation Reduces Infection Risk in Patients With Multiple Myeloma Receiving Teclistamab
For patients with multiple myeloma who may experience an infection while receiving teclistamab, supplementation with intravenous immunoglobulin (IVIG) can help resolve and prevent serious complications.